HB1816
To Prohibit Healthcare Providers And Healthcare Insurers From Using Artificial Intelligence In The Delivery Of Healthcare Services Or The Generation Of Medical Records Unless Certain Requirements Are Met.
Last Action (March 17, 2025): WITHDRAWN BY AUTHOR
Sponsors
AI-Generated Summary
House Bill 1816 prohibits healthcare providers and healthcare insurers in Arkansas from using artificial intelligence (AI) in the delivery of healthcare services or the generation of medical records unless specific criteria are met. To be authorized for use, the AI system must be approved by the United States Food and Drug Administration (FDA) and verified by a quality assurance laboratory for accuracy, reliability, safety, and ethical standards. The bill defines artificial intelligence as a machine-based system capable of making predictions, recommendations, or decisions. It establishes definitions for covered health benefit plans and insurers while providing specific exemptions, such as for dental, vision, long-term care, and workers' compensation plans. The primary goal is to regulate the integration of AI tools within the state's healthcare infrastructure to ensure patient safety and quality standards.
Potential Impact Analysis
Who Might Benefit?
Patients are the primary beneficiaries, as the bill aims to ensure that any artificial intelligence used in their care or documentation meets federal approval and verified safety standards. This may lead to increased confidence in clinical diagnostics and administrative accuracy, potentially protecting them from errors or biases inherent in unvetted algorithmic decision-making.
Who Might Suffer?
Healthcare providers, medical facilities, and healthcare insurers will face increased regulatory burdens and compliance costs associated with securing FDA approval and third-party laboratory verification for their AI tools. Developers and vendors of AI software that do not yet meet these specific legal requirements may see their products restricted or excluded from the Arkansas market, potentially limiting innovation or the deployment of new medical technologies in the state.
Get Notified
Receive an email when this bill's status changes.